The effect of methylenetetrahydrofolate reductase polymorphism C677T on cervical cancer in Korean women

Gynecologic Oncology

Volumn 95, Issue 3, 2004, Pages 557-563

  Sull, Jae Woong ^a   Jee, Sun Ha ^b   Yi, Sangwook ^c   Lee, Jong Eun ^d   Park, Jong Sup ^e   Kim, Sook ^d   Ohrr, Heechoul ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

^c Kwandong University College of Medicine   (South Korea)

^d DNA Link Inc   (South Korea)

^e The Catholic University of Korea   (South Korea)

Author keywords

Cervical cancer; MTHFR; Polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ADULT; ARTICLE; CANCER INVASION; CANCER RISK; CARCINOGENESIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENVIRONMENTAL FACTOR; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INTERMETHOD COMPARISON; KOREA; MAJOR CLINICAL STUDY; PARITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; SEXUAL INTERCOURSE; SMOKING; UTERINE CERVIX CANCER; WART VIRUS;

ADULT; AGED; ALLELES; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, GENETIC; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 9944231595     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.08.008     Document Type: Article

References (29)

1. L. Todesco, C. Angst, P. Litynski, F. Loehrer, B. Fowler, and W.E. Haefeli Methylenetetra-hydrofolate reductase polymorphism, plasma homocysteine and age Eur. J. Clin. Invest. 29 1999 1993 1999
2. S.J. Weinstein, R.G. Ziegler, J. Selhub, T.R. Fears, H.D. Strickler, and L.A. Brinton Elevated serum homocysteine levels and increased risk of invasive cervical cancer in US women Cancer Causes Control 12 2001 317 324
3. S.J. Duthie Folic acid deficiency and cancer: mechanisms of DNA instability Br. Med. Bull. 55 1999 578 592
4. S.M. Zhang, W.C. Willett, J. Selhub, D.J. Hunter, E.L. Giovannucci, and M.D. Holmes Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer J. Natl. Cancer Inst. 95 2003 373 380
5. C. La Vecchia, E. Negri, C. Pelucchi, and S. Franceschi Dietary folate and colorectal cancer Int. J. Cancer 102 2002 545 547
6. B.M. Fowler, A.R. Giuliano, C. Piyathilake, M. Nour, and K. Hatch Hypomethylation in cervical tissue: Is there a correlation with folate status? Cancer Epidemiol., Biomarkers Prev. 7 1998 901 906
7. I. Eto, and C.L. Krumdieck Role of vitamin B12 and folate deficiencies in carcinogenesis Adv. Exp. Med. Biol. 206 1986 313 330
8. M.F. Paz, S. Avila, M.F. Fraga, M. Pollan, G. Capella, and M.A. Peinado Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors Cancer Res. 62 2002 4519 4524
9. P.A. Jones, and P.W. Laird Cancer epigenetics comes of age Nat. Genet. 21 1999 163 167
10. M. Esteller, and J.G. Herman Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours J. Pathol. 196 2002 1 7
11. M.T. Goodman, K. McDuffie, B. Hernandez, L.R. Wilkens, C.C. Bertram, and J. Killeen Association of methylenetetrahydrofolate reductase polymorphism C677T and dietary folate with the risk of cervical dysplasia Cancer Epidemiol., Biomarkers Prev. 10 2001 1275 1280
12. C.J. Piyathilake, M. Macaluso, G.L. Johanning, M. Whiteside, D.C. Heimburger, and A. Giuliano Methylenetetrahydrofolate reductase (MTHFR) polymorphism increases the risk of cervical intraepithelial neoplasia Anticancer Res. 20 2000 1751 1757
13. A.F. Lambropoulos, T. Agorastos, Z.J. Foka, S. Chrisafi, T.C. Constantinidis, and J. Bontis Methylenetetrahydrofolate reductase polymorphism C677T is not associated to the risk of cervical dysplasia Cancer Lett. 91 2003 187 191
14. D.S. Gerhard, L.T. Nguyen, Z.Y. Zhang, I.B. Borecki, B.I. Coleman, and J.S. Rader A relationship between methylenetetrahydrofolate reductase variants and the development of invasive cervical cancer Gynecol. Oncol. 90 2003 560 565
15. C.M. Croce, G. Sozzi, and K. Huebner Role of FHIT in human cancer J. Clin. Oncol. 17 1999 1618 1624
16. J. Lin, M.R. Spitz, Y. Wang, M.B. Schabath, I.P. Gorlov, and L.M. Hernandez Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study Carcinogenesis 2004
17. A. Ulvik, E.T. Evensen, E.A. Lien, G. Hoff, S.E. Vollset, and B.M. Majak Smoking, folate and methylenetetrahydrofolate reductase status as interactive determinants of adenomatous and hyperplastic polyps of colorectum Am. J. Med. Genet. 101 2001 246 254
18. S.B. Baylin, M. Esteller, M.R. Rountree, K.E. Bachman, K. Schuebel, and J.G. Herman Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer Hum. Mol. Genet. 10 2001 687 692
19. M.A. Flynn, V. Herbert, G.B. Nolph, and G. Krause Atherogenesis and the homocysteine-folate-cobalamin triad: do we need standardized analyses? J. Am. Coll. Nutr. 16 1997 258 267
20. F. Breiburd, N. Ramoz, J. Salmon, and G. Orth HLA control in the progression of human papillomavirus infection Semin. Cancer Biol. 7 1996 359 371
21. M.F. Parker, G.F. Arroyo, J. Geradts, A.L. Sabichi, R.C. Park, and R.R. Taylor Molecular characterization of adenocarcinoma of the cervix Gynecol. Oncol. 64 1997 242 251
22. S.S. Kang, P.W. Wong, A. Susmano, J. Sora, M. Norusis, and N. Ruggie Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease Am. J. Hum. Genet. 48 1991 536 545
23. S.H. Jee, K.S. Song, W.H. Shim, H.K. Kim, I. Suh, and J.Y. Park Major gene evidence after MTHFR-segregation analysis of serum homocysteine in families of patients undergoing coronary arteriography Hum. Genet. 111 2002 128 135
24. C.E. Butterworth Jr., K.D. Hatch, M. Macaluso, P. Cole, H.E. Sauberlich, and S.J. Soong Folate deficiency and cervical dysplasia JAMA 267 1992 528 533
25. M.T. Goodman, K. McDuffie, B. Hernandez, L.R. Wilkens, and J. Selhub Case-control study of plasma folate, homocysteine, vitamin B(12), and cysteine as markers of cervical dysplasia Cancer 89 2000 376 382
26. S.J. Weinstein, R.G. Ziegler, E.A. Frongillo Jr., N. Colman, H.E. Sauberlich, and L.A. Brinton Low serum and red blood cell folate are moderately, but nonsignificantly associated with increased risk of invasive cervical cancer in U.S. women J. Nutr. 131 2001 2040 2048
27. A.F. Subar, G. Block, and L.D. James Folate intake and food sources in the US population Am. J. Clin. Nutr. 50 1989 508 516
28. E.W. Gunter, B.A. Bowman, S.P. Caudill, D.B. Twite, M.J. Adams, and E.J. Sampson Results of an international round robin for serum and whole-blood folate Clin. Chem. 42 1996 1689 1694
29. A. Hildsheim, M. Schiffman, D.R. Scott, D. Marti, T. Kissner, and M.E. Sherman Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States Cancer Epidemiol., Biomarkers Prev. 7 1998 1035 1041